Comparative Study Between Different Duty Cycles of Ultrasound Diclofenac Phonophoresis

NCT ID: NCT05158985

Last Updated: 2021-12-15

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 76 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2020-05-15
• Study Completion Date: 2022-11-01

Brief Summary

Lateral epicondylitis is a tendinopathy injury involving the extensor muscles of the forearm. These muscles originate on the lateral epicondylar region of the distal humerus. the insertion of the extensor carpi radialis brevis is involved in most cases. Transdermal administration of an anti-inflammatory drug to specific area is one of the methods that used to decrease inflammation and increase cell metabolism

Detailed Description

Lateral epicondylitis is a soft-tissue lesion of the tendinous origin of the wrist extensor muscles at their origin on the lateral humeral epicondyle. The extensor carpi radialis brevis is the area of most pathologic changes. It begins as a microtear of the tendinous origin of the wrist extensor muscles and results in degeneration and reactive granulation tissue formation. Activities involving prolonged or repeated gripping, wrist extension, forearm supination, and pronation cause eventual failure of the affected portion of the tendon. The mechanical failure of the tendon results in an ensuring tendinitis and symptoms of lateral epicondylitis. It is aggravated with movements of the wrist, by palpation of the lateral side of elbow, or by contraction of extensor muscles of the wrist.

There are different treatment methods for lateral epicondylitis. Initially, lateral epicondylitis has been treated with ice, rest, counterforce tennis brace and/or non-steroidal anti-inflammatory drugs. But when the condition is not responding to initial treatment physical therapy is initiated

Conditions

Undefined

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

group A

diclofenac sodium phonophoresis using continuous ultrasound with a frequency of 1MHz, an intensity of 1.5W/Cm2 for 4 minutes

Group Type: EXPERIMENTAL

phonophoresis

Intervention Type: OTHER

treatment

group B

diclofenac sodium phonophoresis using pulsed US with 1:1 duty cycle with a frequency of 1MHz, an intensity of 1.5W/Cm2 for 4 minutes

Group Type: EXPERIMENTAL

phonophoresis

Intervention Type: OTHER

treatment

group C

diclofenac sodium phonophoresis using pulsed US with 1:4 duty cycle with a frequency of 1MHz, an intensity of 1.5W/Cm2 for 10 minutes

Group Type: EXPERIMENTAL

phonophoresis

Intervention Type: OTHER

treatment

group D

exercises only in form of (strengthening, stretching and occupational exercises).

Group Type: EXPERIMENTAL

exercises

Intervention Type: OTHER

treatment

Interventions

phonophoresis

treatment

Intervention Type: OTHER

exercises

treatment

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. Both sexes will be involved

2. Duration of the disease is more than 12 weeks.

3. Patient's age ranges from 20 to 40 years

Exclusion Criteria

1. Diabetic patients.

2. Hypertension patients.

3. Pregnant women

4. Cardiovascular patients

5. Patients with malunion fractures

6. Patients with cervical Radiclopathy

7. Patients with olecranon bursitis

• Minimum Eligible Age: 20 Years
• Maximum Eligible Age: 40 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

October 6 University

OTHER

Sponsor Role: lead

Responsible Party

basma osama

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Emad MOHAMED

Cairo, , Egypt

Site Status: RECRUITING

Countries

Egypt

Facility Contacts

Emad MOHAMED

Role: primary

Omdamohamed9111@gmail.com

01146808839

Other Identifiers

6786

Identifier Type: -

Identifier Source: org_study_id